BACKGROUND: Post-opioid toxic encephalopathy is described associated with the synthetic opioid, methadone, and after heroin intoxication, (inhaled, injected or ingested). METHODS: We describe the clinical and radiologic findings of a 46-year-old man with oxycodone and oxycontin overdose who developed multifocal encephalopathy and severe cerebellitis causing acute obstructive hydrocephalus, and discuss the possible mechanisms involved. RESULTS: Brain MRI showed a non-vascular distribution of diffusion positive lesions in both cerebellar hemispheres and globi pallidi with preserved cerebral perfusion, suggesting an inflammatory process. Management required ventilatory support and intraventricular catheter placement. CONCLUSIONS: To our knowledge, this is the first report of this condition associated with oxycodone and oxycontin ingestion. The occurrence of this rare toxic encephalopathy may be related to distribution patterns of opioid receptor subtypes, genetic susceptibility, sensitization, and other specific comorbidities.
BACKGROUND: Post-opioid toxic encephalopathy is described associated with the synthetic opioid, methadone, and after heroin intoxication, (inhaled, injected or ingested). METHODS: We describe the clinical and radiologic findings of a 46-year-old man with oxycodone and oxycontinoverdose who developed multifocal encephalopathy and severe cerebellitis causing acute obstructive hydrocephalus, and discuss the possible mechanisms involved. RESULTS: Brain MRI showed a non-vascular distribution of diffusion positive lesions in both cerebellar hemispheres and globi pallidi with preserved cerebral perfusion, suggesting an inflammatory process. Management required ventilatory support and intraventricular catheter placement. CONCLUSIONS: To our knowledge, this is the first report of this condition associated with oxycodone and oxycontin ingestion. The occurrence of this rare toxic encephalopathy may be related to distribution patterns of opioid receptor subtypes, genetic susceptibility, sensitization, and other specific comorbidities.
Authors: J Schadrack; F Willoch; S Platzer; P Bartenstein; B Mahal; D Dworzak; H J Wester; W Zieglgänsberger; T R Tölle Journal: Neuroreport Date: 1999-02-25 Impact factor: 1.837
Authors: E C Wolters; G K van Wijngaarden; F C Stam; H Rengelink; R J Lousberg; M E Schipper; B Verbeeten Journal: Lancet Date: 1982-12-04 Impact factor: 79.321
Authors: A R Kriegstein; D C Shungu; W S Millar; B A Armitage; J C Brust; S Chillrud; J Goldman; T Lynch Journal: Neurology Date: 1999-11-10 Impact factor: 9.910
Authors: Anna Zanin; Susanna Masiero; Maria Savina Severino; Milena Calderone; Liviana Da Dalt; Anna Maria Laverda Journal: J Child Neurol Date: 2009-10-06 Impact factor: 1.987